(Q45310642)

12 December 2017

Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt. (English)

1 reference

12 December 2017

0 references

0 references

1 reference

1 reference

4

Hans U Häring

1 reference

12 December 2017

1

Cora Weigert

1 reference

12 December 2017

5

Erwin D Schleicher

1 reference

12 December 2017

Anita M Hennige

2

1 reference

PubMed ID

15755769

12 December 2017

Katrin Brodbeck

series ordinal

3

1 reference

12 December 2017

8 March 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

12 December 2017

1 reference

12 December 2017

289

1 reference

12 December 2017

E251-7

1 reference

12 December 2017

2

1 reference

Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha.

12 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Insulin resistance, inflammation, and serum fatty acid composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Searching for the exercise factor: is IL-6 a candidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Unravelling the activation mechanisms of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

The "glycogen shunt" in exercising muscle: A role for glycogen in muscle energetics and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Induction of adiponectin gene expression in human myotubes by an adiponectin-containing HEK293 cell culture supernatant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00448.2004

10.1152/AJPENDO.00448.2004

21 January 2018

Identifiers

DOI

1 reference

12 December 2017

1 reference

PubMed ID

15755769